Ellison D J, Turner R R, Van Antwerp R, Martin S E, Nathwani B N
University of Southern California, School of Medicine, Los Angeles 90033.
Cancer. 1987 Dec 1;60(11):2717-20. doi: 10.1002/1097-0142(19871201)60:11<2717::aid-cncr2820601123>3.0.co;2-k.
A 66-year-old man with a 6-month history of sweating at night, generalized lymphadenopathy, hepatosplenomegaly, and paraproteinemia was diagnosed to have a Stage IV mantle zone lymphoma (MZL), which behaved aggressively. The neoplasm rapidly disseminated to extranodal sites--the skin, lungs, pleural cavity, and the central nervous system. The neoplasm did not respond to initial double-agent chemotherapy, but it did partially respond to multi-agent chemotherapy. In addition, the neoplasm had histopathologic features not reported previously in MZL--vascular invasion, massive extranodal infiltration, high mitotic count, and convoluted nuclei.